IMV Technologies is the world leader in animal artificial insemination, embryo transfer and veterinary imaging.

0

History

0

Geographies

0

Patents

A Montagu Business

  • Clear global market leader with 25-50% global market shares across key verticals
  • Resilient and growing underlying market, expected to grow by 4% p.a. until 2025
  • Significant additional growth avenues via product innovation and expansion into adjacent markets
  • High revenue visibility with c. 50% of revenue recurring in nature (and a higher percentage of profits)

Accelerating growth and driving product innovation

We are supporting management to:

  • Continue investment in R&D in order to accelerate the realisation of current and new projects, and continue to gain market share by increasing IMV’s competitive edge
  • Continue IMV’s acquisition strategy in order to penetrate new verticals and expand in key geographies
  • Invest in human capital to support the next phase of growth
  • Invest in processes and systems to improve the organisation’s agility

Deal details


Year of entry

2021


Country

France


Status

In Portfolio


Industry Sector

Healthcare

Back to all portfolio